Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system

American Journal of Clinical Pathology

Volumn 133, Issue 5, 2010, Pages 802-808

  Lee, Hee Jin ^a   Choi, Jene ^a   Hwang, Tae Sook ^b   Shong, Young Kee ^a   Hong, Suck Joon ^a   Gong, Gyungyub ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

BRAF; Fine needle aspiration; Papillary carcinoma; Polymerase chain reaction; Thyroid

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; DNA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; CANCER SURGERY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID CANCER; THYROID NODULE; THYROIDECTOMY; ADENOCARCINOMA; COMPARATIVE STUDY; DNA MICROARRAY; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PATHOLOGY; PREDICTION AND FORECASTING;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NODULE; THYROIDECTOMY;

EID: 77951930488     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPO3F2ENKMDTUS     Document Type: Article

References (32)

1. Peyssonnaux C, Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell. 2001;93:53-62. (Pubitemid 33040860)
2. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
3. Michaloglou C, Vredeveld LC, Mooi WJ, et al. BRAF(E600) in benign and malignant human tumours. Oncogene. 2008;27:877-895. (Pubitemid 351225383)
4. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007;28:742-762. (Pubitemid 350294294)
5. Kim KH, Kang DW, Kim SH, et al. Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J. 2004;45:818-821. (Pubitemid 39545368)
6. Kim TY, Kim WB, Rhee YS, et al. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2006;65:364-368.
7. Chung KW, Yang SK, Lee GK, et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf). 2006;65:660-666.
8. Kim SK, Kim DL, Han HS, et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol. 2008;17:118-125.
9. Kim SK, Song KH, Lim SD, et al. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid. 2009;19:137-141.
10. Cohen Y, Rosenbaum E, Clark DP, et al. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res. 2004;10:2761-2765.
11. Xing M, Tufano RP, Tufaro AP, et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab. 2004;89:2867-2872. (Pubitemid 38766378)
12. Sapio MR, Posca D, Troncone G, et al. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allelespecific PCR amplification (MASA). Eur J Endocrinol. 2006;154:341-348. (Pubitemid 43308839)
13. Jarry A, Masson D, Cassagnau E, et al. Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E. Mol Cell Probes. 2004;18:349-352. (Pubitemid 39061042)
14. Dote H, Tsukuda K, Toyooka S, et al. Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP. Oncol Rep. 2004;11:361-363.
15. Elisei R, Ugolini C, Viola D, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab. 2008;93:3943-3949.
16. Chun JY, Kim KJ, Hwang IT, et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res. 2007;35:e40. doi:10.1093/nar/gkm051.
17. Cao H, Hearst JE, Corash L, et al. LC-MS/MS for the detection of DNA interstrand cross-links formed by 8-methoxypsoralen and UVA irradiation in human cells. Anal Chem. 2008;80:2932-2938. (Pubitemid 351556458)
18. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008;21(suppl 2):S37-S43.
19. 2005 Annual Report of Disease Registry in Korea. Seoul, Korea: Ministry for Health, Welfare and Family Affairs; 2007.
20. Guan H, Ji M, Bao R, et al. Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab. 2009;94:1612-1617.
21. Kim JY, Moon SJ, Kim KR, et al. Dietary iodine intake and urinary iodine excretion in normal Korean adults. Yonsei Med J. 1998;39:355-362.
22. Kim JY, Kim KR. Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J. 2000;41:22-28. (Pubitemid 30154811)
23. Jin L, Sebo TJ, Nakamura N, et al. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol. 2006;15:136-143. (Pubitemid 44325474)
24. Ahmadian A, Ehn M, Hober S. Pyrosequencing: history, biochemistry and future. Clin Chim Acta. 2006;363:83-94.
25. Spittle C, Ward MR, Nathanson KL, et al. Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. J Mol Diagn. 2007;9:464-471. (Pubitemid 47434113)
26. Jo YS, Huang S, Kim YJ, et al. Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas. Clin Endocrinol (Oxf). 2009;70:139-144.
27. Brownie J, Shawcross S, Theaker J, et al. The elimination of primer-dimer accumulation in PCR. Nucleic Acids Res. 1997;25:3235-3241.
28. Ailenberg M, Silverman M. Controlled hot start and improved specificity in carrying out PCR utilizing touch-up and loop incorporated primers (TULIPS). Biotechniques. 2000;29:1018-1020, 1022-1024.
29. Lee JH, Lee ES, Kim YS. Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer. 2007;110:38-46. (Pubitemid 46986416)
30. Santarpia L, Sherman SI, Marabotti A, et al. Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma. Hum Pathol. 2009;40:827-833.
31. Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations. Am J Clin Pathol. 2003;120:71-77. (Pubitemid 37046372)
32. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092-2098.